Around 50% of asthma attacks and 30% of COPD attacks are "eosinophilic exacerbations" – which means they should respond to IL-5 inhibitors like Fasenra that specifically target this type of ...

It’s notable that other attempts to reposition anti-inflammatory biologics for COPD – including IL-5 inhibitors, like GSK’s Nucala (mepolizumab) and AstraZeneca’s Fasenra (benralizumab ...

Chronic obstructive pulmonary disease articles from across Nature Portfolio Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of ...

What is asthma? What are the causes and symptoms of asthma and asthmatic bronchitis? Find the latest research and information on asthma attacks, treatment options and medications.